Xilio Therapeutics, Inc. (XLO) stock
XLONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3080% below fair value
$7.54−0.16 (-2.08%)
Close on Nov 17, 2026Market cap $43.60MP/E –Yield –
Xilio Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Xilio Therapeutics's total assets was $154.25M at Jun 30, 2026. For fiscal 2025 it was $154.69M, up 117.6% from the year before. The highest annual figure on record is $218.06M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $154.69M | +117.6% |
| FY2024 | Dec 31, 2024 | $71.08M | +16.7% |
| FY2023 | Dec 31, 2023 | $60.93M | -56.2% |
| FY2022 | Dec 31, 2022 | $139.17M | -36.2% |
| FY2021 | Dec 31, 2021 | $218.06M | +500.4% |
| FY2020 | Dec 31, 2020 | $36.32M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $154.25M | +15.3% |
| Q1 FY2026 | Mar 31, 2026 | $163.49M | +57.6% |
| Q4 FY2025 | Dec 31, 2025 | $154.69M | +117.6% |
| Q3 FY2025 | Sep 30, 2025 | $133.69M | +79.1% |
| Q2 FY2025 | Jun 30, 2025 | $133.81M | +48.9% |
| Q1 FY2025 | Mar 31, 2025 | $103.72M | +25.6% |
| Q4 FY2024 | Dec 31, 2024 | $71.08M | +16.7% |
| Q3 FY2024 | Sep 30, 2024 | $74.66M | -4.1% |
| Q2 FY2024 | Jun 30, 2024 | $89.87M | -2.7% |
| Q1 FY2024 | Mar 31, 2024 | $82.61M | -25.9% |
| Q4 FY2023 | Dec 31, 2023 | $60.93M | -56.2% |
| Q3 FY2023 | Sep 30, 2023 | $77.84M | -50.5% |
| Q2 FY2023 | Jun 30, 2023 | $92.36M | -48.1% |
| Q1 FY2023 | Mar 31, 2023 | $111.51M | -43.2% |
| Q4 FY2022 | Dec 31, 2022 | $139.17M | -36.2% |
| Q3 FY2022 | Sep 30, 2022 | $157.41M | +30.4% |
| Q2 FY2022 | Jun 30, 2022 | $178.13M | +390.5% |
| Q1 FY2022 | Mar 31, 2022 | $196.35M | – |
| Q4 FY2021 | Dec 31, 2021 | $218.06M | – |
| Q3 FY2021 | Sep 30, 2021 | $120.73M | – |
| Q4 FY2020 | Dec 31, 2020 | $36.32M | – |
See a number that looks wrong?